Cellectis S.A.
- Last sale
- Nov 12, 2026 · +2.29%
- Market cap
- —
- no share count on file
- Filings
- 538
FY 2025+75.8% FY25 yoy
FY 2025N/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025derivedN/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025−57.0% FY25 yoy
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $72,949,000 | reported | |
| FY 2024 | 2024-12-31 | $41,505,000 | reported | |
| FY 2023 | 2023-12-31 | $755,000 | reported | |
| FY 2022 | 2022-12-31 | $19,171,000 | reported | |
| FY 2021 | 2021-12-31 | $30,347,000 revised | reported | |
| FY 2020 | 2020-12-31 | $51,057,000 revised | reported | |
| FY 2019 | 2019-12-31 | $15,190,000 | reported | |
| FY 2018 | 2018-12-31 | $12,731,000 | reported | |
| FY 2017 | 2017-12-31 | $25,188,000 | reported | |
| FY 2016 | 2016-12-31 | $44,808,000 | reported | |
| FY 2015 | 2015-12-31 | $55,864,000 | reported |
Segments
LineFY2025ShareChange
France$72.95M100%+75.8%
Other European Countries———
United States———
Total$72.95M
Biological products, except diagnostic substances
Cellectis S.A. is the 36th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
FDMT4D Molecular Therapeutics, Inc.$85.2M230,194.6%164.4%$682.1MMGTXMeiraGTx Holdings plc$81.4M144.6%140.3%$858.1MAUTLAutolus Therapeutics plc$75.4M644.9%381.4%$318.3MRXRXRecursion Pharmaceuticals, Inc.$74.7M26.9%863.4%$2.1B
CLLSCellectis S.A. (this company)$72.9M75.8%92.7%—
CGENCompugen Ltd$72.8M161.1%48.6%$200.5MBDTXBlack Diamond Therapeutics, Inc.$70.0M—32.0%$86.8MVIRVir Biotechnology, Inc.$68.6M7.6%638.9%$2.1BCSBRChampions Oncology, Inc.$59.4M4.4%2.0%$76.4MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Cellectis S.A. · CIK 1627281 · Engraved from SEC EDGAR